Furthermore, inhibiting HIF-1α significantly reduced HCV replication in hepatoma cell lines and primary hepatocytes, highlighting a dual role for this transcription factor in the viral life cycle and hepatoma migration. This evidence concerns the gene HIF1A and hepatocellular carcinoma.